David Risinger

Leerink Partners | Healthcare

David Risinger is an analyst from Leerink Partners specializing in the Healthcare sector. Ranked #1197 out of 4779 analysts, they have issued 18 stock ratings with a success rate of 78.78% and an average return of 38.13%.

With 18 ratings to date, David Risinger is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 78.78% and an average return of 38.13%, highlighting promising potential as their track record develops further.

#1197

Out of 4779

18

Total Ratings

+78.78%

Success Rate

+38.13%

Average Return

Recent Ratings Analysis

ENTX

Sep 18, 2026

Target

$9.00

Current

$3.03

Performance

—

David Risinger rated ENTX as Outperform on Sep 18, 2026, setting a price target of 9. Shares have remained stable near 3.03, leaving the 9 target still in play.

LTGO

Sep 01, 2026

Target

$36.00

Current

$23.93

Performance

7.50%

On Sep 01, 2026, LTGO was given a Outperform rating by David Risinger, with a target price of 36. The stock rallied 7.50% after the rating, narrowing the gap to the target of 36 and validating the bullish stance.

LLY

Jun 25, 2026

Target

$1232.00

Current

$1152.13

Performance

2.17%

LLY received a Outperform rating from David Risinger on Jun 25, 2026, aiming for 1232. Price action was muted, as shares hovered around 1152.13 despite the bullish outlook.

JNJ

May 13, 2026

Target

$265.00

Current

$270.22

Performance

17.27%

On May 13, 2026, David Risinger published a Outperform outlook on JNJ, with a target of 265. Shares gained 17.27%, underscoring the accuracy of the bullish outlook toward 265.

KLRA

May 12, 2026

Target

$36.00

Current

$12.92

Performance

-42.06%

David Risinger on May 12, 2026 assigned KLRA a Outperform rating, with a price target of 36. The call has struggled to gain traction, with shares losing 42.06%.

ANAB

Apr 28, 2026

Target

$85.00

Current

$55.06

Performance

-16.71%

On Apr 28, 2026, David Risinger reaffirmed ANAB with a Outperform rating, targeting 85. Shares slid 16.71% despite the recommendation, highlighting downside risks.

CNTA

Apr 01, 2026

Target

$40.00

Current

$40.50

Performance

1.61%

CNTA was rated Market Perform by David Risinger on Apr 01, 2026, with a price objective of 40. Flat performance suggests the Hold view was reasonable.

ORKA

Mar 16, 2026

Target

$86.00

Current

$97.73

Performance

134.08%

On Mar 16, 2026, David Risinger initiated coverage on ORKA with a Outperform rating and target of 86. The stock’s climb of 134.08% since the call highlights the foresight in the rating.

AMGN

Feb 04, 2026

Target

$355.00

Current

$379.78

Performance

3.71%

David Risinger issued a Outperform recommendation for AMGN on Feb 04, 2026, price target set at 355. The target of 355 remains in play, though confirmation will depend on future moves.

BMY

Jan 13, 2026

Target

$60.00

Current

$62.84

Performance

12.37%

On Jan 13, 2026, BMY was evaluated by David Risinger, who gave a Outperform rating and target of 60. This case illustrates how a timely bullish rating can translate into tangible gains of 12.37%.

VRTX

Dec 29, 2025

Target

$525.00

Current

$516.34

Performance

12.30%

David Risinger rated VRTX as Outperform on Dec 29, 2025, setting a price target of 525. The call has proven timely, with shares rising 12.30% toward the price target of 525.

ROIV

Dec 15, 2025

Target

$32.00

Current

$39.98

Performance

82.56%

On Dec 15, 2025, ROIV was given a Outperform rating by David Risinger, with a target price of 32. The stock rallied 82.56% after the rating, narrowing the gap to the target of 32 and validating the bullish stance.

XOMA

Dec 11, 2025

Target

$58.00

Current

$40.17

Performance

51.36%

XOMA received a Outperform rating from David Risinger on Dec 11, 2025, aiming for 58. Momentum has favored the Buy call, with shares climbing from 40.17 to 40.17, rewarding those who trusted the recommendation.

IMA

Oct 24, 2025

Target

$30.00

Current

$5.02

Performance

-37.25%

On Oct 24, 2025, David Risinger published a Outperform outlook on IMA, with a target of 30. Market action contradicted the Buy thesis, as shares slipped to 5.02.

HALO

Oct 14, 2025

Target

$70.00

Current

$109.68

Performance

64.56%

David Risinger on Oct 14, 2025 assigned HALO a Market Perform rating, with a price target of 70. Shares outperformed expectations, climbing 64.56% despite the neutral view.

MTSR

Sep 24, 2025

Target

$57.00

Current

$70.50

Performance

34.29%

On Sep 24, 2025, David Risinger reaffirmed MTSR with a Market Perform rating, targeting 57. Market strength beyond 70.5 went further than the conservative outlook suggested.

REGN

Feb 05, 2025

Target

$834.00

Current

$789.45

Performance

10.15%

REGN was rated Outperform by David Risinger on Feb 05, 2025, with a price objective of 834. A bullish response from the market helped close the gap of 44.55 to the target.

ABBV

Nov 22, 2024

Target

$206.00

Current

$264.00

Performance

49.19%

On Nov 22, 2024, David Risinger initiated coverage on ABBV with a Outperform rating and target of 206. The stock’s climb of 49.19% since the call highlights the foresight in the rating.

TECX

Nov 11, 2024

Target

$69.00

Current

$27.21

Performance

-40.94%

David Risinger issued a Outperform recommendation for TECX on Nov 11, 2024, price target set at 69. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

PCVX

Sep 03, 2024

Target

$153.00

Current

$60.37

Performance

-45.19%

On Sep 03, 2024, PCVX was evaluated by David Risinger, who gave a Outperform rating and target of 153. Investors saw limited payoff as shares fell short of the 153 target.

HLVX

Jul 09, 2024

Target

$2.00

Current

$2.09

Performance

23.67%

David Risinger rated HLVX as Market Perform on Jul 09, 2024, setting a price target of 2. Despite the Hold call, shares climbed 23.67% to 2.09, revealing unexpected momentum.

Frequency Asked Questions

Who is David Risinger?

David Risinger is an analyst from Leerink Partners specializing in the Healthcare sector.

What is David Risinger's success rate?

David Risinger currently has a success rate of +78.78%.

How many ratings has David Risinger issued?

David Risinger has issued 18 stock ratings so far.

What is the average return of David Risinger's calls?

Their stock ratings have generated an average return of +38.13%.

What is David Risinger's ranking?

David Risinger is ranked #1197 out of 4779 analysts.

What types of ratings does David Risinger give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Risinger?

You can follow David Risinger by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Risinger?

Their latest rating was a Buy on ENTX issued on 2026-09-18.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep